MARKET

HBMHF

HBMHF

Hbm Hldgs
OTCPK
2.520
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
2.520
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.520
52 WEEK LOW
0.905
MARKET CAP
2.19B
P/E (TTM)
26.58
1D
5D
1M
3M
1Y
5Y
1D
Biotech Outperformance - Can't Take What's Already Earned
Seeking Alpha · 05/09 09:37
Harbour BioMed Names Youchen Chen CFO; Stock Up
NASDAQ · 04/10 05:52
About HBMHF
Hbm Holdings Ltd is an investment holding company primarily engaged in the business of developing innovative therapeutics in the fields of immuno-oncology and immunology diseases. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The Company provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.

Webull offers Hbm Holdings Ltd stock information, including OTCPK: HBMHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBMHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBMHF stock methods without spending real money on the virtual paper trading platform.